Issues in the pharmacological modification of cocaine conditioning: Evidence that the stimulus properties of drugs can interact with contextual cues to activate or inactivate cocaine conditioned stimuli

Behavioural Brain Research

Volumn 101, Issue 2, 1999, Pages 189-206

  Carey, Robert ^a   Damianopoulos, Ernest ^a   DePalma, Gail ^a  

^a SYRACUSE VA MEDICAL CENTER   (United States)

Author keywords

Buspirone; Cocaine; Drug stimuli; Grooming; Locomotion; MK 801; Pavlovian conditioning

Indexed keywords

BUSPIRONE; COCAINE; DIZOCILPINE; MORPHINE; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; GROOMING; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

ANIMALS; BRAIN; BUSPIRONE; COCAINE; CONDITIONING, OPERANT; CUES; DIZOCILPINE MALEATE; DOPAMINE UPTAKE INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; GROOMING; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGONISTS;

EID: 0032909216     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(98)00149-1     Document Type: Article

References (51)

1. Ahmed S.H., Cador M., Le Moal M., Stinus L. Amphetamine-induced conditioned activity in rats: comparison with novelty-induced activity and role of the basolateral amygdala. Behav. Neurosci. 109:1995;723-733.
2. Ahmed S.H., Stinus L., Le Moal M., Cador M. Controlling interindividual differences in the unconditioned response to amphetamine in the study of environment-dependent sensitization. Behav. Pharmacol. 4:1993;355-365.
3. Cador M., Bjijou Y., Stinus L. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience. 65:1995;385-395.
4. 1B receptor agonists. Neuropharmacology. 36:1997;373-381.
5. Carelzon W.A. Jr., Mendrek A., Wise R.A. MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation. Synapse. 20:1995;1-9.
6. Carey R.J. Pavlovian conditioning of L-DOPA induced movement. Psychopharmacology. 107:1992;203-210.
7. Carey R.J., Damianopoulos E.N. Activation of an apomorphine behavior pattern by cocaine: a new behavioral test for drug substitution. J. Neurosci. Methods. 46:1993;1-10.
8. Carey R.J., Gui J. Cocaine conditioning and cocaine sensitization: what is the relationship? Behav. Brain Res. 92:1998;67-76.
9. Carey R.J., Gui J. Cocaine sensitization can accelerate the onset of peak cocaine behavioral effects. Pharmacol. Biochem. Behav. 60:1998;395-405.
10. Cervo L., Samanin R. Effects of dopaminergic and glutaminergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res. 673:1995;242-250.
11. Cervo L., Samanin R. Effects of dopaminergic and glutaminergic receptor antagonists on the establishment of conditioned locomotion to cocaine in rats. Brain Res. 731:1996;31-38.
12. Cooper S.J., Van der Hoek G.A. Cocaine: a microstructural analysis of its effects on feeding and associated behaviour in the rat. Brain Res. 608:1993;45-51.
13. Corbett R. Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue. Pharmacol. Biochem. Behav. 51:1995;561-564.
14. Cox J., Westbrook R.F. The NMDA receptor antagonist MK-801 blocks acquisition and extinction of conditioned hypalgesic responses in the rat. Q. J. Exp. Psychol. 47:1994;187-210.
15. Damianopoulos E.N., Carey R.J. A new method to assess Pavlovian conditioning of psychostimulant drug effects. J. Neurosci. Methods. 53:1994;7-17.
16. Damianopoulos E.N., Carey R.J. Evidence for NMDA receptor mediation of cocaine induced corticosterone release and cocaine conditioned stimulant effects. Behav. Brain Res. 68:1995;219-228.
17. Damianopoulos E.N., Carey R.J. Selective blockade of cocaine conditioned behavior with Buspirone. Soc. Neurosci. Abstr. 22:1996;922.
18. De Montis M.G., Devoto P., Meloni D., Gambarana C., Giorgi G., Tagliamonte A. NMDA receptor inhibition prevents tolerance to cocaine. Pharmacol. Biochem. Behav. 42:1992;179-182.
19. Eikelboom R., Stewart J. Conditioning of drug-induced physiological responses. Psychol. Rev. 89:1982;507-528.
20. Greeley J., Lee D.A., Poulos C.X., Cappel H. Alcohol is an effective cue in the conditional control of tolerance to alcohol. Psychopharmacology. 83:1984;159-162.
21. Hinson R.E., Poulos C.X. Sensitization to the behavioral effects of cocaine: Modification by Pavlovian conditioning. Pharmacol. Biochem. Behav. 15:1981;559-562.
22. Karler R., Calder L.D., Bedingfield J.B. Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology. 115:1994;305-310.
23. Kim H.S., Park W.K., Jang C.G., Oh S. Inhibition by MK-801 of cocaine-induced sensitization, conditioned place, preference, and dopamine-receptor supersensitivity in mice. Brain Res. Bull. 40:1996;201-207.
24. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
25. Kropf W., Kuschinsky K. Conditioned effects of apomorphine are manifest in regional EEG of rats both in hippocampus and in striatum. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;487-493.
26. Kropf W., Kuschinsky K., Krieglstein J. Conditioning of apomorphine effects: simultaneous analysis of the alterations in cortical electroencephalogram and behaviour. Naunyn-Schmiedeberg's Arch. Pharmacol. 343:1991;559-567.
27. Lienau A.K., Kuschinsky K. Sensitization phenomena after repeated administration of cocaine or D-amphetamine in rats: associative and non-associative mechanisms and the role of dopamine in the striatum. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:1997;531-537.
28. Martin G.E. The effects of pairings of pentobarbital with lithium chloride on the capacity of pentobarbital to maintain a conditioned aversion. Behav. Neural Biol. 39:1983;145-148.
29. Pavlov I.P. Lectures on Conditioned Reflexes. 1928;International, New York.
30. Pechnick R.N., George R., Poland R.E. Characterization of the effects of the acute and repeated administration of MK-801 on the release of adrenocorticotropin, corticosterone and prolactin in the rat. Eur. J. Pharmacol. 164:1989;257-263.
31. Pickens R., Dougherty J. Conditioning of the activity effects of drugs. Thompson T., Schuster C. Stimulus Properties of Drugs. 1971;39-50 Appleton-Century-Crofts, New York.
32. Pontieri F.E., Tanda G., DiChiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA. 92:1992;12304-12308.
33. Poulos C.X., Cappell H. Homeostatic theory of drug tolerance: a general model of physiological adaptation. Psychol. Rev. 98:1991;390-408.
34. Pudiak C.M., Bozarth M.A. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci. 53:1993;1517-1524.
35. Schenk S., Valadez A., McNamara C., House D.T., Higley D., Bankson M.G., Gibbs S., Horger B.A. Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors. Psychopharmacology. 111:1993;332-338.
36. Schiff S.R. Conditioned dopaminergic activity. Biol. Psychiatry. 17:1982;135-154.
37. Siegel S. Pharmacological conditioning and drug effects. Goudie A.J., Emmett-Ogglesby M. Psychoactive Drugs. 1989;115-180 The Humana Press, New York.
38. Solomon R.L. An opponent-process theory of acquired motivation. The affective dynamics of addiction. Maser J.D., Seligman M.E.P. Psychopathology: Experimental Models. 1977;35-49 W.H. Freeman, San Francisco.
39. Stewart J., Druhan J.P. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology. 110:1993;125-132.
40. Stewart J., Eikelboom R. Conditioned Drug Effects. 1987;Plenum Press, New York.
41. Stewart J., Vezina P. Extinction procedures abolish conditioned stimulus control but spare sensitized responding to amphetamine. Behav. Pharmacol. 2:1991;65-71.
42. Tebbett I.R. Rapid extraction of cocaine and morphine in whole blood for HPLC analysis. Chromatographia. 23:1987;377-378.
43. Tilson H.A., Rech R.A. Conditioned drug effects and absence of tolerance to d-amphetamine induced motor activity. Pharmacol. Biochem. Behav. 1:1973;149-153.
44. Tzschentke T.M., Schmidt W.J. N-Methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci. Lett. 193:1995;37-40.
45. Tzschentke T.M., Schmidt W.J. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization. Behav. Brain Res. 84:1997;99-107.
46. Welsch-Kunze S., Kuschinsky K. On the possible involvement of glutamate receptors in conditioning of behavioural effects of apomorphine. Psychopharmacology. 101:1990;421-428.
47. Wessinger W.D. Tolerance to and dependence on MK-801 (dizocilpine) in rats. Pharmacol. Biochem. Behav. 49:1994;1049-1056.
48. Wise R.A., Mendrek A., Carelzon W.A. Jr. MK-801 (dizocilpine): synergist and conditioned stimulus in bromocriptine-induced psychomotor sensitization. Synapse. 22:1996;362-368.
49. Wolf M.E., Jeziorski M. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res. 613:1993;291-294.
50. Woolverton W.L., Johnson K.M. Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13:1992;193-200.
51. Zajaczkowski W., Moryl E., Papp M. Discriminative stimulus effects of the NMDA receptor antagonists MK-801 and CGP 37849 in rats. Pharmacol. Biochem. Behav. 55:1996;163-168.